Price data is not available
Harvard Bioscience Inc (HBIO) Stock Price, Quote, News & History
HBIONASDAQ
Harvard Bioscience restructures production, closing MA plant, shifting output to US and abroad. Savings expected, costs until 2027.
You can purchase shares of Harvard Bioscience (NASDAQ:HBIO) through any online brokerage.
Other companies in Harvard Bioscience’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Harvard Bioscience has a consensus price target of $18.75.
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $8.18 last updated October 20, 2026 at 5:51 PM EDT.
There are no upcoming dividends for Harvard Bioscience.
Harvard Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Harvard Bioscience.
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The...
